Mirum Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIRM and other ETFs, options, and stocks.

About MIRM

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. 

CEO
Christopher Peetz
CEOChristopher Peetz
Employees
372
Employees372
Headquarters
Foster City, California
HeadquartersFoster City, California
Founded
2018
Founded2018
Employees
372
Employees372

MIRM Key Statistics

Market cap
6.16B
Market cap6.16B
Price-Earnings ratio
-6.20
Price-Earnings ratio-6.20
Dividend yield
—
Dividend yield—
Average volume
704.24K
Average volume704.24K
High today
$95.38
High today$95.38
Low today
$91.46
Low today$91.46
Open price
$91.85
Open price$91.85
Volume
626.47K
Volume626.47K
52 Week high
$130.00
52 Week high$130.00
52 Week low
$63.23
52 Week low$63.23

Stock Snapshot

As of today, Mirum Pharmaceuticals(MIRM) shares are valued at $94.42. The company's market cap stands at 6.16B, with a P/E ratio of -6.20.

On 2026-11-10, Mirum Pharmaceuticals(MIRM) stock moved within a range of $91.46 to $95.38. With shares now at $94.42, the stock is trading +3.2% above its intraday low and -1.0% below the session's peak.

Trading activity shows a volume of 626.47K, compared to an average daily volume of 704.24K.

The stock's 52-week range extends from a low of $63.23 to a high of $130.00.

The stock's 52-week range extends from a low of $63.23 to a high of $130.00.

MIRM News

Seeking Alpha 10h
Mirum succeeds in second late-stage trial for hepatitis D therapy

Mirum succeeds in second late-stage trial for hepatitis D therapy Nov 10, 2026, 1:26 PM ET Mirum Pharmaceuticals, Inc. (MIRM) Stock By : Dulan Lokuwithana, SA N...

Mirum succeeds in second late-stage trial for hepatitis D therapy
Investing.com 6d
Mirum Pharmaceuticals CEO Peetz sells $1.8M in stock - Investing.com

...

Mirum Pharmaceuticals CEO Peetz sells $1.8M in stock - Investing.com

Analyst ratings

100%

of 15 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own MIRM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.